Ticker Details
Axsome Therapeutics, Inc. Axsome Therapeutics Inc is a pharmaceutical company in the United States. It focuses on developing novel therapeutics for the redressal of diseases related to the central nervous system.
IPO Date:	November 19, 2015
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$9.26B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.21 | 2.90%
Avg Daily Range (30 D):	$2.34 | 1.29%
Avg Daily Range (90 D):	$2.66 | 1.74%

Institutional Daily Volume
Avg Daily Volume:	.61M
Avg Daily Volume (30 D):	.53M
Avg Daily Volume (90 D):	.51M

Trade Size
Avg Trade Size (Sh.):	75
Avg Trade Size (Sh.) (30 D):	41
Avg Trade Size (Sh.) (90 D):	40

Institutional Trades
Total Institutional Trades:	3,566
Avg Institutional Trade:	$3.3M
Avg Institutional Trade (30 D):	$11.94M
Avg Institutional Trade (90 D):	$8.66M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$4.11M
Avg Closing Trade (30 D):	$12.46M
Avg Closing Trade (90 D):	$10.53M
Avg Closing Volume:	54.2K

News

Jan 8, 2026 @ 3:06 PM Biotech Is Heating Up—These 2 Red-Hot Stock... Source: Nathan Reiff

Jan 8, 2026 @ 10:15 AM 2 Healthcare Stocks to Buy for 2026 and Beyond Source: Prosper Junior Bakiny

Dec 31, 2025 @ 12:00 PM Axsome Therapeutics Announces FDA Acceptance and P... Source: Na

Dec 2, 2025 @ 1:06 AM 2 Under-the-Radar Stocks to Buy Heading Into 2026 Source: Prosper Junior Bakiny

Nov 20, 2025 @ 12:00 PM Axsome Therapeutics to Participate in Upcoming Inv... Source: Axsome Therapeutics

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-4.67	$-.94	$-.97
Diluted EPS	$-4.67	$-.94	$-.97
Revenue	$561.26M	$170.99M	$150.04M
Gross Profit
Net Income / Loss	$-229.53M	$-47.23M	$-47.97M
Operating Income / Loss	$-212.42M	$-46.11M	$-36.71M
Cost of Revenue
Net Cash Flow	$-2.07M	$22.26M	$2.11M
PE Ratio